News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
New pathobiology studies look to accelerate RECOVER’s progress
The next phase of RECOVER’s pathobiology studies will focus on discoveries that can more immediately inform efforts to diagnose, prevent, and treat Long COVID.
Feature
73 Results
73 Results
Pregnancy and pediatric studies work together to learn how COVID affects mothers and their babies
Babies whose mothers had COVID while pregnant will help RECOVER researchers understand how the mother’s COVID case could impact childhood development.
Feature
R3 Seminar Recap: Using RECOVER biosamples to advance your research
On January 13, 2026, RECOVER hosted the second webinar in its 2-part series to help prospective researchers use biosamples from the initiative’s observational studies. RECOVER has made over 1.4 million biosamples available for study across the human lifespan, including 24,000 samples from its tissue pathology (autopsy) study. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
R3 Seminar Recap
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
Food insecurity and adverse social conditions tied to increased risk of Long COVID in children
In a study published in JAMA Pediatrics, RECOVER researchers analyzed data from over 4,500 school-aged children and adolescents to understand the relationship between social risk factors and the risk for developing Long COVID.
Announcement
R3 Seminar Recap: Using RECOVER data to advance your research
On December 9, 2025, the RECOVER Initiative hosted the first webinar in a two-part series to help researchers use data from the initiative’s observational studies to advance Long COVID research. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.
R3 Seminar Recap
RECOVER Research Update: December 2025
Researchers across the initiative continue to refine methods to accurately identify Long COVID, learn more about potential treatments, and understand how the condition impacts different groups of people.
Research Update
Over 1.4 million biosamples available in RECOVER’s biorepository to support Long COVID research
Biostatisticians and clinicians work together to help funded study teams access resources stored in RECOVER’s biorepository, a unique collection of biosamples from almost 30,000 adults and children.
Feature
Study reveals insights into Long COVID trajectories in adults
A study from Mass General Brigham followed 3,659 adults to identify eight different paths that Long COVID can take, based on symptoms and length of illness. The results will inform future studies and possible treatments for Long COVID.
News Release